ESC Working Group Position Statement: Diagnosis and Treatment of Cardiac Amyloidosis (2021)

Outlines red flags for suspicion, diagnostic pathways, imaging, biopsy, and management of cardiac amyloidosis subtypes (ATTR-CM and AL-CM).